A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Sheba Medical Center to Integrate Elbit Systems Advanced Military Thermal Imaging Technology

Sheba Medical Center, Israel’s largest medical center and a Newsweek top-10 ranked world’s best hospital for the last four years, announced today that is has signed a Memorandum of Understanding (MoU) with Opgal, a subsidiary of Elbit Systems, to utilize advanced thermal imaging technologies previously used for military and security purposes. The integration of the thermal imaging cameras intends to improve the efficiency and efficacy of surgery and treatment in four key areas: heart surgery, diabetic foot treatment, surgical incision infections and respiratory monitoring.

Thermal photography, best known for its role in the world of defense and aerospace, offers significant potential for healthcare. Using thermal cameras, physicians can detect physiological processes based on changes in energy and heat in the body and display these changes on a digital screen. Used in the medical setting, this technology can enable doctors and surgeons to accurately identify the movement of blood vessels and present a clear picture of carbon dioxide being emitted by exhalation.

“The new relationship between medical excellence and excellence in the defense industry is groundbreaking,” said Prof. Eyal Zimlichman, Sheba’s chief innovation and transformation officer, and head of ARC. “The solutions worked on by Elbit and Opgal experts and Sheba doctors are not only significant for Sheba and Israel but will have an international impact. These are global solutions to global problems, and we believe there is great potential here to change the face of medicine on an international level.”

Using these new technological developments, Sheba medical teams will be able to receive previously unavailable new information in real time, for the purpose of formulating increasingly accurate medical diagnoses. The photographed materials will also be analyzed at Sheba using artificial intelligence tools and will enter a computerized database for future use by doctors in decision making.

Sheba Medical Center is leading the digital transformation to advanced digital medicine in Israel and around the world. Sheba, through its innovation arm, ARC (Accelerate, Redesign, Collaborate), is building and maintaining close collaborations and projects with the world’s best hospitals and leading companies in the industry, such as the one with Opgal and Elbit Systems.

“Thermal technology, which until now has helped pilots take off and land, and soldiers on the battlefield identify threats and targets, has the potential to help medical teams worldwide to see the invisible and make more accurate diagnoses,” said Tsachi Israel, CEO of Opgal. “We are the leading experts in our respective fields, working together to innovate in order to save lives and prevent suffering for many patients.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

SABIC advises the project was initiated together with the dialysis department at Jessa Hospital, one of the largest non-university medical cluster in the Limburg region of Flanders, Belgium.
Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines

By using this website you agree to accept Medical Device News Magazine Privacy Policy